Amazon's meeting with FDA starts the rumor mill turning

Amazon ($AMZN) is the latest tech giant to consider expanding into healthcare, but details of the online retailer's plans are sketchy. VentureBeat speculates that Amazon could have arranged its recent meeting with the FDA to discuss a health data platform, wearable technology or the online sale of prescription drugs. Article

Suggested Articles

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.